REJURAN COSMETICS, a medical aesthetic brand developed by the pharmaceutical biotechnology company PharmaResearch, has debuted at Sephora with its products now available on the retailer's website and scheduled to roll out to approximately 380 physical stores across the United States starting March 16. The product lineup available through this partnership includes the Turnover Ampoule, Dual Effect Ampoule, Rebalancing Toner, Nutritive Cream, and Turnover Mask, along with a Sephora-exclusive mini set designed to introduce consumers to the range at a lower entry point.
Central to REJURAN COSMETICS' positioning is its use of a patented c-PDRN ingredient derived from sustainably sourced wild salmon DNA. This substance is combined with proprietary DNA Optimizing Technology. The resulting complex supports skin renewal processes by strengthening the foundations of healthy skin and improves texture, hydration, and radiance.
Medical Aesthetic Brand Expansions
REJURAN COSMETICS Enters Sephora
Trend Themes
-
Pharma-backed Beauty — The convergence of pharmaceutical R&D with consumer skincare indicates potential for clinically validated, prescription-adjacent products to reshape mainstream beauty categories.
-
Biotech-derived Active Ingredients — Sustainably sourced c-PDRN and similar biotechnology actives are positioned to redefine efficacy benchmarks and regulatory frameworks for cosmetic claims.
-
Retail-exclusive Trial Formats — Sephora-exclusive mini sets and lower-entry product formats point to new distribution-led packaging strategies that can accelerate consumer trial and category penetration.
Industry Implications
-
Retail Cosmetics — Premium beauty retailers incorporating medical aesthetic brands could drive assortment shifts toward clinically backed SKUs and new merchandising models.
-
Pharmaceutical Biotechnology — Pharma companies expanding into consumer-facing cosmetics reveal opportunities to commercialize proprietary biologics and leverage clinical credibility outside traditional healthcare channels.
-
Sustainable Marine Biotech — Commercial use of wild salmon DNA extracts highlights demand for scalable, traceable marine sourcing and innovations in sustainable ingredient production.